Task: Answer the multiple-choice question.
Question: Which compound exhibits a -13.783% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCc1ccc(OCC(O)CN2CCCC2)cc1.Cl
b.) COc1ccc(NC(=O)N2CCCC(C(=O)NCc3ccccc3F)C2)cc1
c.) CCCC(C)NC(=O)c1ccc2[nH]c3c(c2c1)CC(C)CC3
Answer: a. CCc1ccc(OCC(O)CN2CCCC2)cc1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1ccc(OCC(O)CN2CCCC2)cc1.Cl
CCc1ccc(OCC(O)CN2CCCC2)cc1.Cl
1-(4-ethylphenoxy)-3-pyrrolidin-1-ylpropan-2-ol;hydrochloride